688 related articles for article (PubMed ID: 18621108)
1. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Candelario-Jalil E; Yang Y; Rosenberg GA
Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
3. Multiple roles for MMPs and TIMPs in cerebral ischemia.
Cunningham LA; Wetzel M; Rosenberg GA
Glia; 2005 Jun; 50(4):329-339. PubMed ID: 15846802
[TBL] [Abstract][Full Text] [Related]
4. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
Walker EJ; Rosenberg GA
Exp Neurol; 2009 Mar; 216(1):122-31. PubMed ID: 19111539
[TBL] [Abstract][Full Text] [Related]
5. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.
Machado LS; Kozak A; Ergul A; Hess DC; Borlongan CV; Fagan SC
BMC Neurosci; 2006 Jul; 7():56. PubMed ID: 16846501
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases in neuroinflammation.
Rosenberg GA
Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
[TBL] [Abstract][Full Text] [Related]
7. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
8. Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.
Swann K; Berger J; Sprague SM; Wu Y; Lai Q; Jimenez DF; Barone CM; Ding Y
Brain Res; 2007 Jan; 1129(1):26-33. PubMed ID: 17156757
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
Leppert D; Lindberg RL; Kappos L; Leib SL
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.
Rosenberg GA; Estrada EY; Dencoff JE
Stroke; 1998 Oct; 29(10):2189-95. PubMed ID: 9756602
[TBL] [Abstract][Full Text] [Related]
12. The role of the matrix metalloproteinases during in vitro vessel formation.
Burbridge MF; Cogé F; Galizzi JP; Boutin JA; West DC; Tucker GC
Angiogenesis; 2002; 5(3):215-26. PubMed ID: 12831062
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria.
Van den Steen PE; Van Aelst I; Starckx S; Maskos K; Opdenakker G; Pagenstecher A
Lab Invest; 2006 Sep; 86(9):873-88. PubMed ID: 16865090
[TBL] [Abstract][Full Text] [Related]
14. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia.
Rosenberg GA; Yang Y
Neurosurg Focus; 2007 May; 22(5):E4. PubMed ID: 17613235
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.
Haorah J; Ramirez SH; Schall K; Smith D; Pandya R; Persidsky Y
J Neurochem; 2007 Apr; 101(2):566-76. PubMed ID: 17250680
[TBL] [Abstract][Full Text] [Related]
18. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
19. Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis.
Miao Q; Baumgärtner W; Failing K; Alldinger S
Acta Neuropathol; 2003 Nov; 106(5):486-94. PubMed ID: 12920537
[TBL] [Abstract][Full Text] [Related]
20. Role of matrix metalloproteinases in animal models of ischemic stroke.
Lenglet S; Montecucco F; Mach F
Curr Vasc Pharmacol; 2015; 13(2):161-6. PubMed ID: 24188490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
